Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
Conditions: HBV; HCC Intervention: Drug: nucleoside analogues or interferon Sponsors: Wen-hong Zhang; Shandong Provincial Hospital Affiliated to Shandong First Medical University; First Affiliated Hospital Xi'an Jiaotong University; The Affiliated Hospital of Xuzhou Medical University; First Affiliated Hospital of Fujian Medical University; The Third People's H ospital of Taiyuan; The First People's Hospital of Yunnan; The First Affiliated Hospital of Anhui Medical University; Wuhan Union Hospital, China; The First Affiliated Hospital with Nanjing Medical University ...
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects.
Condition: Chronic Hepatitis b Interventions: Drug: AB-101; Drug: Placebo; Drug: Nucleos(t)ide Analogue Sponsor: Arbutus Biopharma Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
